StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
29
Publishing Date
2023 - 09 - 26
1
2023 - 08 - 14
1
2023 - 06 - 29
1
2023 - 04 - 18
1
2023 - 03 - 01
1
2023 - 02 - 08
1
2023 - 01 - 19
1
2023 - 01 - 06
2
2023 - 01 - 04
1
2022 - 12 - 08
1
2022 - 11 - 30
1
2022 - 10 - 17
1
2022 - 10 - 11
1
2022 - 09 - 21
1
2022 - 09 - 14
1
2022 - 08 - 02
1
2022 - 06 - 15
1
2022 - 04 - 07
1
2022 - 02 - 28
1
2022 - 02 - 17
1
2021 - 12 - 20
1
2021 - 12 - 15
1
2021 - 12 - 07
1
2021 - 11 - 11
1
2021 - 10 - 07
1
2021 - 08 - 17
1
2021 - 08 - 10
1
2021 - 07 - 14
1
Sector
Administrative and support and waste management and remediation services
1
Commercial services
30
Communications
17
Consumer non-durables
5
Consumer services
1
Distribution services
5
Electronic technology
8
Finance
12
Finance and insurance
1
Health care and social assistance
1
Health services
66
Health technology
1014
Industrial services
1
Information
4
Manufacturing
83
Mining, quarrying, and oil and gas extraction
1
Miscellaneous
2
N/a
36
Non-energy minerals
2
Process industries
14
Producer manufacturing
4
Professional, scientific, and technical services
29
Real estate and rental and leasing
1
Retail trade
2
Technology services
37
Transportation
4
Wholesale trade
4
Tags
Acquisition
52
Agreement
52
Alzheimer’s
54
Application
60
Biopharma
91
Biotech-beach
52
Biotechnology
58
Business
115
Cancer
141
Ceo
47
Clinical-trials-phase-ii
48
Collaboration
49
Conference
417
Day
52
Disease
139
Drug
79
Earnings
81
Events
149
Fda
74
Financial
336
Financial results
102
Genetown
60
Genomics
45
Global
173
Group
41
Growth
150
Health
107
Management
57
Market
301
Meeting
112
Molecular
71
N/a
2940
Nasdaq
49
Offering
167
One
51
People
86
Pharm-country
60
Pharmaceuticals
111
Phase 2
55
Positive
94
Pre-clinical
44
Preclinical
86
Presentation
85
Program
64
Publication
56
Report
216
Research
209
Results
586
Rosa
42
Services
76
Software
51
Study
80
Technology
56
Test
47
Therapeutics
698
Therapy
77
Treatment
123
Trial
208
Update
183
Year
154
Entities
Agilent technologies, inc.
1
Akoya biosciences inc
2
Alzamend neuro inc
2
Ambrx biopharma inc - adr
1
Bio-techne corp
1
Briacell therapeutics corp.
3
Century therapeutics inc
1
Compass therapeutics inc
1
Day one biopharmaceuticals inc
2
Dynamics special purpose corp class a
1
Elevation oncology inc
1
Entrada therapeutics inc
1
Finch therapeutics group inc
2
Illumina, inc.
1
Immunoprecise antibodies ltd
1
Ironwood pharmaceuticals, inc.
1
Ispecimen inc
1
Jazz pharmaceuticals plc
1
Moderna, inc.
1
Morgan stanley
1
Panbela therapeutics inc
1
Qiagen n.v.
1
Quoin pharmaceuticals ltd - adr
4
Recursion pharmaceuticals inc - class a
1
Seer inc - class a
1
Singular genomics systems inc
1
Takeda pharmaceutical company limited
1
Transcode therapeutics inc
1
Vectivbio holding ag
1
Vertex pharmaceuticals incorporated
1
Werewolf therapeutics inc
1
Zentek ltd.
1
Symbols
A
1
AKYA
2
ALZN
2
AMAM
1
BCTX
3
CMPX
1
DAWN
2
DYNS
1
ELEV
1
FNCH
2
HOWL
1
ILMN
1
IPA
1
IPSC
1
IRWD
1
ISPC
1
JAZZ
1
MRNA
1
MS
1
OMIC
1
PBLA
1
QGEN
1
QNRX
4
RNAZ
1
RXRX
1
SEER
1
TAK
1
TECH
1
TRDA
1
VECT
1
VRTX
1
ZTEK
1
Exchanges
Nasdaq
28
Nyse
5
Crawled Date
2023 - 09 - 26
1
2023 - 08 - 14
1
2023 - 06 - 29
1
2023 - 04 - 19
1
2023 - 03 - 01
1
2023 - 02 - 08
1
2023 - 01 - 19
1
2023 - 01 - 06
2
2023 - 01 - 04
1
2022 - 12 - 08
1
2022 - 11 - 30
1
2022 - 10 - 17
1
2022 - 10 - 11
1
2022 - 09 - 21
1
2022 - 09 - 14
1
2022 - 08 - 02
1
2022 - 06 - 15
1
2022 - 04 - 07
1
2022 - 02 - 28
1
2022 - 02 - 17
1
2021 - 12 - 20
1
2021 - 12 - 15
1
2021 - 12 - 07
1
2021 - 11 - 11
1
2021 - 10 - 07
1
2021 - 08 - 17
1
2021 - 08 - 10
1
2021 - 07 - 14
1
Crawled Time
00:00
1
12:00
4
13:00
6
13:30
1
14:00
11
14:20
2
14:30
1
15:00
1
15:30
1
17:00
1
Source
www.biospace.com
29
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
sector :
Professional, scientific, and technical services
tags :
Alliances
save search
Panbela Announces Issuance of New Patent in China for Claims of a Novel Process for the Production of SBP-101Patent developed in collaboration with Syngene International Ltd.
Published:
2023-09-26
(Crawled : 13:00)
- biospace.com/
PBLA
|
$0.525
-6.31%
38K
|
Professional, Scientific, and T...
|
-97.92%
|
O:
0.0%
H:
9.6%
C:
2.4%
sbp-101
patent
international
collaboration
china
BIO-TECHNE ENDS COLLABORATION PROGRAM WITH AKOYA TO AUTOMATE RNASCOPE ON THE PHENOCYCLER FUSION
Published:
2023-08-14
(Crawled : 13:00)
- biospace.com/
AKYA
|
$3.92
-1.51%
-1.53%
180K
|
Professional, Scientific, and T...
|
-34.0%
|
O:
0.66%
H:
0.0%
C:
-7.58%
TECH
|
$62.7
-2.05%
-2.09%
900K
|
Health Technology
|
-25.67%
|
O:
-0.83%
H:
1.57%
C:
1.34%
collaboration
program
Ironwood and VectivBio Announce the Completion of the Tender Offer for VectivBio Shares
Published:
2023-06-29
(Crawled : 14:00)
- biospace.com/
VECT
|
$16.85
0.12%
130K
|
Professional, Scientific, and T...
|
-0.53%
|
O:
-0.06%
H:
0.3%
C:
-0.06%
IRWD
|
$7.66
-2.92%
-3.0%
2.4M
|
Health Technology
|
-27.56%
|
O:
0.09%
H:
1.7%
C:
0.76%
ironwood
Finch Therapeutics Announces Clinical Collaboration in Ulcerative Colitis with Brigham and Women’s Hospital and Updates to University of Minnesota License Agreement
Published:
2023-04-18
(Crawled : 00:00)
- biospace.com/
FNCH
|
$2.5
-19.36%
-24.0%
130K
|
Professional, Scientific, and T...
|
-78.47%
|
O:
-5.18%
H:
7.24%
C:
7.14%
license
hospital
collaboration
therapeutics
agreement
ACE-Breast-02 Pivotal Phase 3 Study of Ambrx’s ARX788 for the Treatment of HER2 Positive Metastatic Breast Cancer Achieves Positive Results
Published:
2023-03-01
(Crawled : 14:00)
- biospace.com/
AMAM
4
|
$28.0
0.0%
1.4M
|
Professional, Scientific, and T...
|
335.46%
|
O:
-0.93%
H:
8.16%
C:
-7.54%
arx788
treatment
breast
positive
cancer
study
her2
antibody-as269
metastatic breast cancer
iSpecimen Expands Biospecimen Provider NetworkiSpecimen Strategically Grows its Proprietary Marketplace Platform with Seven New Biospecimen Sample Providers Across the U.S. and Europe
Published:
2023-02-08
(Crawled : 14:00)
- biospace.com/
ISPC
|
$0.229
7.97%
7.38%
250K
|
Professional, Scientific, and T...
|
-86.88%
|
O:
3.18%
H:
0.55%
C:
-2.48%
europe
platform
Zentek Signs Distribution Agreement with Southmedic Inc.
Published:
2023-01-19
(Crawled : 15:00)
- biospace.com/
ZTEK
|
$1.14
1.33%
13K
|
Professional, Scientific, and T...
|
-22.45%
|
O:
0.68%
H:
1.35%
C:
-1.35%
distribution
agreement
Elevation Oncology Announces Pipeline Prioritization, Realignment of Resources to Advance EO-3021 and CEO Transition
Published:
2023-01-06
(Crawled : 14:00)
- biospace.com/
ELEV
|
$4.15
-5.47%
-5.78%
500K
|
Professional, Scientific, and T...
|
318.1%
|
O:
-6.67%
H:
1.02%
C:
-23.47%
eo-3021
ceo
Agilent and Akoya Biosciences Announce Partnership to Drive Multiplex Tissue Assay Development for Biopharma Applications
Published:
2023-01-06
(Crawled : 14:00)
- biospace.com/
AKYA
|
$3.92
-1.51%
-1.53%
180K
|
Professional, Scientific, and T...
|
-56.12%
|
O:
0.99%
H:
8.95%
C:
8.41%
A
|
$134.55
-1.65%
-0.85%
2.1M
|
Health Technology
|
-10.07%
|
O:
1.48%
H:
0.18%
C:
-4.33%
partnership
biopharma
Alzamend Neuro Partners With Biorasi to Conduct a First-in-Human, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Phase I/IIA Clinical Trial
Published:
2023-01-04
(Crawled : 14:00)
- biospace.com/
ALZN
|
$0.7241
-5.01%
-5.28%
58K
|
Professional, Scientific, and T...
|
31.43%
|
O:
3.45%
H:
0.0%
C:
-3.35%
trial
group
Vertex and Entrada Therapeutics Establish Collaboration to Discover and Develop Endosomal Escape Vehicle (EEV) Therapeutics for Myotonic Dystrophy Type 1 (DM1)
Published:
2022-12-08
(Crawled : 13:00)
- biospace.com/
TRDA
|
$12.22
-3.93%
-4.09%
56K
|
Professional, Scientific, and T...
|
-31.04%
|
O:
8.92%
H:
12.12%
C:
8.81%
VRTX
|
$393.1
-0.27%
-0.27%
880K
|
Health Technology
|
23.78%
|
O:
-0.01%
H:
2.27%
C:
1.19%
collaboration
therapeutics
IPA’s Subsidiary BioStrand and BriaCell Announce Artificial Intelligence Collaboration and License Agreement to Discover and Develop Anti-Cancer Antibodies
Published:
2022-11-30
(Crawled : 14:00)
- biospace.com/
IPA
|
$1.29
3.88%
59K
|
Professional, Scientific, and T...
|
-74.75%
|
O:
-0.6%
H:
1.0%
C:
-1.19%
BCTX
|
$2.19
-5.6%
-5.94%
140K
|
Professional, Scientific, and T...
|
-50.89%
|
O:
-1.07%
H:
1.62%
C:
-3.42%
collaboration
license
agreement
Day One Announces Cooperative Research and Development Agreement with National Cancer Institute to Expand Development of Tovorafenib (DAY101)
Published:
2022-10-17
(Crawled : 14:00)
- biospace.com/
DAWN
4
|
$14.87
1.78%
1.75%
800K
|
Professional, Scientific, and T...
|
-30.03%
|
O:
2.35%
H:
0.98%
C:
-7.96%
day101
day
research
one
agreement
cancer
Compass Therapeutics Announces Clinical Collaboration with Merck to Evaluate CTX-471 in Combination with KEYTRUDA® (pembrolizumab)
Published:
2022-10-11
(Crawled : 14:20)
- biospace.com/
CMPX
|
$1.52
-3.19%
-3.29%
120K
|
Professional, Scientific, and T...
|
-44.72%
|
O:
0.7%
H:
13.64%
C:
8.04%
ctx-471
keytruda
collaboration
therapeutics
Foundation Medicine and Day One Biopharmaceuticals Announce Global Collaboration to Advance Pediatric Cancer Care
Published:
2022-09-21
(Crawled : 12:00)
- biospace.com/
DAWN
4
|
$14.87
1.78%
1.75%
800K
|
Professional, Scientific, and T...
|
-25.76%
|
O:
-0.2%
H:
0.0%
C:
-6.82%
day
care
global
collaboration
one
cancer
BriaCell Partners with Caris Life Sciences® to Expand Patient Outreach and Molecular Profiling
Published:
2022-09-14
(Crawled : 14:20)
- biospace.com/
BCTX
|
$2.19
-5.6%
-5.94%
140K
|
Professional, Scientific, and T...
|
-65.76%
|
O:
-0.25%
H:
2.86%
C:
0.75%
sciences
life
molecular
TransCode Therapeutics and MD Anderson Announce Strategic Alliance to Advance RNA Therapies for Oncology
Published:
2022-08-02
(Crawled : 17:00)
- biospace.com/
RNAZ
|
$0.5
-0.99%
-1.0%
280K
|
Professional, Scientific, and T...
|
-98.19%
|
O:
0.14%
H:
4.2%
C:
1.3%
therapeutics
Quoin Pharmaceuticals Announces Licensing and Distribution Agreement with Leading Rare Disease Company for Greater China
Published:
2022-06-15
(Crawled : 14:00)
- biospace.com/
QNRX
|
$0.703
-2.36%
-2.42%
37K
|
Professional, Scientific, and T...
|
58.32%
|
O:
-2.41%
H:
0.0%
C:
-12.49%
rare
disease
distribution
china
Jazz Pharmaceuticals and Werewolf Therapeutics Announce Exclusive Global License and Collaboration Agreement to Develop WTX-613, a Differentiated, Conditionally-Activated IFNα INDUKINE™ Molecule
Published:
2022-04-07
(Crawled : 12:00)
- biospace.com/
HOWL
|
$5.84
4.1%
3.94%
410K
|
Professional, Scientific, and T...
|
23.47%
|
O:
6.98%
H:
49.21%
C:
15.42%
JAZZ
|
News
|
$107.15
-1.61%
-1.63%
590K
|
Health Technology
|
-34.4%
|
O:
0.0%
H:
4.11%
C:
3.3%
wtx-613
collaboration
license
therapeutics
Singular Genomics Partners with QIAGEN to Enable QIAseq Kits for the G4 Sequencing Platform
Published:
2022-02-28
(Crawled : 14:00)
- biospace.com/
OMIC
|
$0.38
-2.56%
-2.63%
260K
|
Professional, Scientific, and T...
|
-95.15%
|
O:
0.0%
H:
0.0%
C:
0.0%
QGEN
|
$39.23
-0.23%
0.0%
800K
|
Health Technology
|
-19.3%
|
O:
2.78%
H:
1.48%
C:
-0.54%
QGEN
|
$39.23
-0.23%
0.0%
800K
|
Health Technology
|
-19.3%
|
O:
2.78%
H:
1.48%
C:
-0.54%
genomics
genomic
platform
← Previous
1
2
Next →
Gainers vs Losers
56%
44%
Top 10 Gainers
INVO
|
$1.76
131.58%
56.82%
230M
|
Health Technology
SINT
|
$0.0365
59.39%
37.26%
470M
|
Health Technology
WISA
4
|
$9.19
50.66%
33.7%
65M
|
Electronic Technology
EDBL
|
News
|
$6.73
47.91%
32.39%
13M
|
GCTK
|
$0.715
36.27%
26.62%
640K
|
Manufacturing
TCON
|
$2.33
36.26%
26.61%
2M
|
Health Technology
TIRX
|
$0.48
6.43%
24.58%
4.8M
|
KZIA
|
$0.38
30.58%
23.42%
300K
|
Health Technology
VNDA
|
News
|
$5.23
29.14%
22.56%
24M
|
Health Technology
ATNF
|
$1.91
29.05%
22.51%
310K
|
Your saved searches
Save your searches and get alerts when important news are released.